New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 19, 2014
08:32 EDTANAC, SPPIAnacor appoints Paul L. Berns as CEO, effective immediately
Berns succeeds David P. Perry who has served as Anacorís (ANAC) President and CEO since 2002. Berns has over 20 years of industry experience as an executive in biotechnology and pharmaceutical companies. He most recently served as the President and Chief Executive Officer of Allos Therapeutics prior to its acquisition by Spectrum Pharmaceuticals (SPPI) in 2012.
News For ANAC;SPPI From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 26, 2014
17:10 EDTSPPISpectrum reports 16.66% stake in CASI Pharmaceuticals
Spectrum entered into the investment agreements in order to acquire shares of common stock of CASI Pharmaceuticals for investment purposes with the goal of increasing the value of the company as a result of, among other things, CASI's development and commercialization of Zevalin and captisol-enabled melphalan in Greater China.
September 22, 2014
16:07 EDTANACAnacor announces commercial launch of KERYDIN topical solution in U.S.
Subscribe for More Information
11:48 EDTSPPISpectrum management to meet with Roth Capital
Subscribe for More Information
September 18, 2014
07:07 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information
07:05 EDTSPPISpectrum out-licenses rights for Greater China to CASI for three drugs
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use